Viewing Study NCT00097760


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 11:37 PM
Study NCT ID: NCT00097760
Status: COMPLETED
Last Update Posted: 2009-06-18
First Post: 2004-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
Sponsor: Biogen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Relapsing-Remitting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis View
None MS View